Aberdeen Group Boosts Stake in Elevance Health to $101 Million Ahead of Earnings

Aberdeen Group plc has increased its investment in Elevance Health, Inc. (ELV) by 6.1% during the fourth quarter of 2025. According to recent filings, the institutional investor now holds 288,976 shares in the healthcare giant, representing a position valued at approximately $101 million. This strategic accumulation occurs just before the company is scheduled to release its latest quarterly earnings report. Analysts view this move as a signal of strong institutional confidence in the health insurer's long-term growth prospects and market position. The increase reflects a broader trend of institutional interest in the U.S. healthcare sector. Overall, this buildup suggests a positive outlook for ELV's performance as it prepares for its upcoming financial disclosure.